Infectious Diseases Now
Overview
Infectious Diseases Now is a peer-reviewed journal dedicated to providing up-to-date and comprehensive coverage of the latest research and developments in the field of infectious diseases. It publishes original articles, reviews, and case studies, offering valuable insights into the prevention, diagnosis, and treatment of various infectious diseases affecting humans. With a focus on current trends, emerging pathogens, and innovative therapies, this journal serves as a vital resource for healthcare professionals, researchers, and policymakers in the fight against infectious diseases.
Details
Details
Abbr.
Infect Dis Now
Start
2021
End
Continuing
e-ISSN
2666-9919
Country
France
Language
English
Specialty
Infectious Diseases
Metrics
Metrics
h-index / Ranks: 7207
51
SJR / Ranks: 4806
851
CiteScore / Ranks: 3145
6.70
Recent Articles
1.
Lefevre L, Quenard F, Cabras O, Medo E, Barry T, Cabie A, et al.
Infect Dis Now
. 2025 Mar;
:105055.
PMID: 40089154
Objective And Methods: We retrospectively assessed protection against HBV (defined by HBs Ab > 10 UI/L), HAV (defined by positive IgG), and HPV (defined by at least one shot) in...
2.
Zins C, Pailhories H, Chenouard R, Corvec S, Dahyot S, Woerther P, et al.
Infect Dis Now
. 2025 Mar;
:105056.
PMID: 40089153
Objectives: To assess the susceptibility of ceftolozane/tazobactam (C/T) and comparators to Pseudomonas aeruginosa isolates recovered from respiratory-tract-infections (RTI) between 2016-2022 in the French SMART study. Methods: Antibiotic susceptibility testing and...
3.
Elouardi C, Lefort A, Deconinck L, Peiffer-Smadja N, Houze S, Argy N
Infect Dis Now
. 2025 Mar;
55(3):105053.
PMID: 40064469
Loiasis is a vector-borne parasitic disease that has long been neglected due to its benign nature and its geographical distribution, which is restricted to the forest regions of Central and...
4.
Beaudequin N, Glemain B, Fajac A, Rothstein V, Fartoukh M, Voiriot G
Infect Dis Now
. 2025 Mar;
55(3):105054.
PMID: 40057193
Objective: To investigate the response to high-dose corticosteroids according to bronchoalveolar neutrophil-to-lymphocyte ratio (BAL-NLR) in critically-ill COVID-19 patients. Methods: We retrospectively analyzed a single-center cohort of adult COVID-19 patients admitted...
5.
Ting M, Martens M, Albazzaz H, Wolesensky C, Kobic E
Infect Dis Now
. 2025 Mar;
:105052.
PMID: 40054737
Background: Rates of Carbapenem Resistant Enterobacterales (CRE)-related infections in the United States have continued to rise, leading to significant morbidity and mortality. Klebsiella pneumoniae carbapenemases (KPC) have been the most...
6.
Lone M, Naruka Y, Viswhanath S, Pandey A
Infect Dis Now
. 2025 Mar;
55(3):105051.
PMID: 40054736
No abstract available.
7.
Wagner C, Lithopoulos A, Shorr R, Atkins H
Infect Dis Now
. 2025 Mar;
55(3):105050.
PMID: 40043807
Objectives: Autologous hematopoietic stem cell transplantation (aHSCT) offers potential long-term remission for various autoimmune diseases, especially in patients unresponsive to conventional treatments. Notwithstanding its benefits, aHSCT carries risks from cytotoxic...
8.
Palamim C, Marques L, Boschiero M, Marson F
Infect Dis Now
. 2025 Mar;
55(3):105042.
PMID: 40023502
No abstract available.
9.
Zhang Z, Ren Z, Hu P, Li X, Liu S, Wang P, et al.
Infect Dis Now
. 2025 Mar;
55(3):105049.
PMID: 40023501
Objectives: The effectiveness of varicella vaccination strategies needs to be further evaluated. The vaccine effectiveness (VE) of the varicella vaccine was evaluated, and changes in VE of varicella vaccination in...
10.
Besnard A, Korinek A, Bernard R, Abdennour L, Mathon B, Bombled C, et al.
Infect Dis Now
. 2025 Feb;
55(3):105043.
PMID: 40020967
Background: Switching antibiotic therapy from intravenous to oral route (IVOS) has become the standard of care for many deep-seated infections. IVOS seems applicable to intracranial bacterial suppurations (ICBS) with a...